Flaxseed and its mammalian lignan precursor cause a lengthening or cessation of estrous cycling in rats

Cancer Letters

Volumn 125, Issue 1-2, 1998, Pages 69-76

  Orcheson, Lindy J ^a   Rickard, Sharon E ^a   Seidl, Maja M ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antiestrogens; Estrous cycle; Flaxseed; Mammalian lignans; Secoisolariciresinol diglycoside

Indexed keywords

ANTIESTROGEN; LINSEED OIL; SECOISOLARICIRESINOL DIGLYCOSIDE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DIESTRUS; DIET SUPPLEMENTATION; DOSE RESPONSE; ESTRUS CYCLE; FEMALE; LIPID DIET; LIVER WEIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; UTERUS WEIGHT;

ANIMALS; BUTYLENE GLYCOLS; ESTROGEN ANTAGONISTS; ESTRUS; FEMALE; FLAX; LIGNANS; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; MAMMALIA;

EID: 0032513184     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00482-5     Document Type: Article

References (48)

1. Baghurst P.A., Rohan T.E. High fiber diets and reduced risk of breast cancer. Int. J. Cancer. 56:1994;173-176.
2. Howe G.R., Hirohata T., Hislop T.G., Iscovich J.M., Yuan J.M., Katsouyanni K., Lubin F., Marubini E., Modan B., Rohan T. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J. Natl. Cancer Inst. 82:1990;561-569.
3. Block G., Patterson B., Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 18:1992;1-29.
4. Adlercreutz H., Goldin B.R., Gorbach S.L., Hockerstedt K., Watanabe S., Hamalainen E., Markkanen H., Makela T., Wahala K., Hase T., Fotsis T. Soybean phytoestrogen intake and cancer risk. J. Nutr. 125:1995;757S-770S.
5. Adlercreutz H., Mousavi Y., Hockerstedt K. Diet and breast cancer. Acta Oncol. 31:1992;175-181.
6. Franke A.A., Custer L.J., Cerna D.M., Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc. Soc. Exp. Biol. Med. 208:1995;18-26.
7. Thompson L.U., Robb P., Serraino M., Cheung F. Mammalian lignan production from various foods. Nutr. Cancer. 16:1991;43-52.
8. Setchell K.D.R., Lawson A.M., Mitchell F.L., Adlercreutz H., Kirk D.N., Axelson M. Lignans in man and animal species. Nature. 288:1980;740-742.
9. Borriello S.P., Setchell K.D.R., Axelson M., Lawson A.M. Production and metabolism of lignans by the human fecal flora. J. Appl. Bacteriol. 58:1985;37-43.
10. Serraino M., Thompson L.U. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr. Cancer. 17:1992;153-159.
11. Rickard S.E., Orcheson L.J., Seidl M.M., Luyengi L., Fong H.S., Thompson L.U. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J. Nutr. 126:1996;2012-2019.
12. Thompson L.U., Seidl M.M., Rickard S.E., Orcheson L.J., Fong H.S. Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr. Cancer. 26:1996;159-165.
13. Thompson L.U., Rickard S.E., Orcheson L.J., Seidl M.M. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis. 17:1996;1373-1376.
14. Hirano T., Fukuoka K., Oka K., Naito T., Hosaka K., Mitsuhashi H., Matsumoto Y. Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1. Cancer Invest. 8:1990;595-602.
15. Mousavi Y., Adlercreutz H. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J. Steroid Biochem. Mol. Biol. 41:1992;615-619.
16. Sathyamoorthy N., Wang T.T.Y., Phang J.M. Stimulation of pS2 expression by diet-derived compounds. Cancer Res. 54:1994;957-961.
17. Jordan V.C. The strategic use of antiestrogens to control the development and growth of breast cancer. Cancer. 70:1992;977-981.
18. Kvale G. Reproductive factors in breast cancer epidemiology. Acta Oncol. 31:1992;187-194.
19. Bernstein L., Ross R.K., Henderson B.E. Prospects for the primary prevention of breast cancer. Am. J. Epidemiol. 135:1992;142-152.
20. Anonymous, Canadian Council on Animal Care, Guide to the Care and Use of Experimental Animals, Ottawa, Ontario, 1984.
21. American Institute of Nutrition Report of Ad Hoc Committee on Standards of Nutritional Studies. J. Nutr. 107:1977;1340-1348.
22. M.X. Zarrow, J.M. Yochim, J.L. McCarthy, The estrogens, in: M.X. Zarrow, J.M. Yochim, J.L. McCarthy (Eds.), Experimental Endocrinology, A Sourcebook of Basic Techniques, Academic Press, New York, 1964, pp. 17-64.
23. D.E.J. Baker, Reproduction and breeding, in: H.J. Baker, J.R. Lindsey, S.H. Weisbroth (Eds.), The Laboratory Rat: Biology and Diseases, Vol. 1, Academic Press, New York, 1979, pp. 154-168.
24. Kvale G., Heuch I. Menstrual factors and breast cancer risk. Cancer Lett. 62:1988;1625-1631.
25. LaVecchia C., Decarli A., Di Pietro S., Franceschi S., Negri E., Parazzini F. Menstrual cycle patterns and risk of breast disease. Eur. J. Cancer Clin. Oncol. 21:1985;417-422.
26. Frisch R.E., Wyshak G., Albright N.L., Schiff I., Jones K.P., Witschi J., Shiang E., Koff E., Marguglio M. Lower prevalence of cancer of the reproductive system among former college athletes compared to non-athletes. Br. J. Cancer. 52:1985;885-891.
27. Pederson A.B., Bartholomew M.J., Dolence L.A., Aljadir L.P., Netteburg K.L., Lloyd T. Menstrual differences due to vegetarian and nonvegetarian diets. Am. J. Clin. Nutr. 53:1991;879-884.
28. Phipps W.R., Martini M.C., Lampe J.W., Slavin J.L., Kurzer M.S. Effect of flax seed ingestion on the menstrual cycle. J. Clin. Endocrinol. 77:1993;1215-1219.
29. Adlercreutz H., Honjo H., Higashi A., Fotsis T., Hamalainen E., Hasegawa T., Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 54:1991;1093-1100.
30. Katzenellenbogen B.S., Fang H., Ince B.A., Pakdel F., Reese J.C., Wooge C.H., Wrenn C.K. Estrogen receptors: ligand discrimination and antiestrogen action. Breast Cancer Res. Treat. 27:1993;17-26.
31. Adlercreutz H., Mousavi Y., Clark J., Hockerstedt K., Hamalainen E., Wahala K., Makela T., Hase T. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Mol. Biol. 41:1992;331-337.
32. Markaverich B.M., Clark J.H. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotrophic response. Endocrinology. 105:1979;1458-1462.
33. Markaverich B.M., Roberts R.R., Alejandro M.A., Johnson G.A., Middleditch B.S., Clark J.H. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J. Steroid Biochem. 30:1988;71-78.
34. Waters A.P., Knowler J.T. Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. J. Reprod. Fert. 66:1982;379-381.
35. A.V. Nalbandov, The estrous cycle, in: A.V. Nalbandov (Ed.), Reproductive Physiology of Mammals and Birds: The Comparative Physiology of Domestic and Laboratory Animals and Man, WH Freeman, San Francisco, CA, 1976, pp. 98-124.
36. Welshons W.V., Murphy C.S., Koch R., Calaf G., Jordan V.C. Stimulation of breast cancer cells by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res. Treat. 10:1987;169-175.
37. Wilcox G., Wahlqvist M.L., Burger H.G., Medley G. Oestrogenic effects of plant foods in postmenopausal women. Br. Med. J. 301:1990;905-906.
38. Morton M.S., Wilcox G., Wahlqvist M.L., Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142:1994;251-259.
39. H.J. Baker, J.R. Lindsey, S.W. Weisbroth, The Laboratory Rat: Research Applications, Vol. 2, Academic Press, New York, 1980, pp. 257-258.
40. Mazur W., Fotsis T., Wahala K., Ojala S., Salakka A., Adlercreutz H. Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal. Biochem. 233:1996;169-180.
41. Adlercreutz H., Mazur W. Phyto-oestrogens and Western diseases. Ann. Med. 29:1997;95-120.
42. Marshall L.A., Szczesniewski A., Johnston P.V. Dietary linolenic acid and prostaglandin synthesis: a time course study. Am. J. Clin. Nutr. 38:1983;895-900.
43. Auletta F.J., Schofield M.J., Abae M. The mechanisms controlling luteolysis in non-human primates and women. Semin. Reprod. Endocrinol. 8:1990;122-129.
44. Zaccheo T., Guidici D., Di Salle E. Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats. J. Steroid Biochem. Mol. Biol. 44:1993;677-680.
45. Jordan V.C., Murphy C.S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev. 11:1990;578-610.
46. Huynh H.T., Pollack M. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res. 53:1993;5585-5588.
47. Kraus W.L., Katzenellenbogen B.S. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen activities by progesterone and sex steroid hormone antagonists. Endocrinology. 93:1993;2371-2379.
48. Branham W.S., Zehr D.R., Sheehan D.M. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc. Soc. Exp. Biol. Med. 203:1993;297-303.